Imaging features of toxicities associated with immune checkpoint inhibitors

Babina Gosangi, Lacey McIntosh, Abhishek Keraliya, David Victor Kumar Irugu, Akshay Baheti, Ashish Khandelwal, Richard Thomas, Marta Braschi-Amirfarzan

Research output: Contribution to journalArticlepeer-review


The past decade has witnessed a change in landscape of cancer management with the advent of precision oncology. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and have played an important role in improving patient survival. While the patients are living longer, treatment with ICIs are sometimes associated with adverse effects, some of which could be fatal. Radiologists can play a crucial role by early identification of some of these adverse effects during restaging scans. Our paper focuses on the imaging features of commonly occurring ICI toxicities based on organ system.

Original languageEnglish (US)
Article number100434
JournalEuropean Journal of Radiology Open
StatePublished - Jan 2022


  • Colitis
  • Hepatitis
  • Immune check point inhibitors toxicity
  • Pancreatitis
  • Pneumonitis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Imaging features of toxicities associated with immune checkpoint inhibitors'. Together they form a unique fingerprint.

Cite this